These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 2863366
1. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. Hedberg A, Kempf F, Josephson ME, Molinoff PB. J Pharmacol Exp Ther; 1985 Sep; 234(3):561-8. PubMed ID: 2863366 [Abstract] [Full Text] [Related]
2. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells. Barovsky K, Brooker G. J Cyclic Nucleotide Res; 1980 Sep; 6(4):297-307. PubMed ID: 6110683 [Abstract] [Full Text] [Related]
3. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Joyce JN, Lexow N, Kim SJ, Artymyshyn R, Senzon S, Lawrence D, Cassanova MF, Kleinman JE, Bird ED, Winokur A. Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605 [Abstract] [Full Text] [Related]
4. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase. Liang BT, Molinoff PB. J Pharmacol Exp Ther; 1986 Sep; 238(3):886-92. PubMed ID: 2875173 [Abstract] [Full Text] [Related]
5. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. Ordway GA, Gambarana C, Tejani-Butt SM, Areso P, Hauptmann M, Frazer A. J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532 [Abstract] [Full Text] [Related]
6. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Wax MB, Molinoff PB. Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):420-30. PubMed ID: 3030954 [Abstract] [Full Text] [Related]
7. Demonstration of beta 1-adrenergic receptors in human placenta by (-)[125I]iodocyanopindolol binding. Paci A, Cocci F, Piras F, Niedermeyer HP, Matteucci E, Vitali C, Ciarimboli G, Bombardieri S. J Nucl Med Allied Sci; 1989 Mar; 33(1):15-21. PubMed ID: 2545844 [Abstract] [Full Text] [Related]
8. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. Wagner JA, Sax FL, Weisman HF, Porterfield J, McIntosh C, Weisfeldt ML, Snyder SH, Epstein SE. N Engl J Med; 1989 Mar 23; 320(12):755-61. PubMed ID: 2537929 [Abstract] [Full Text] [Related]
9. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. Neve KA, Barrett DA, Molinoff PB. J Pharmacol Exp Ther; 1985 Dec 23; 235(3):657-64. PubMed ID: 2867205 [Abstract] [Full Text] [Related]
11. Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding. Wang XL, Brodde OE. J Cyclic Nucleotide Protein Phosphor Res; 1985 Dec 23; 10(5):439-50. PubMed ID: 2866204 [Abstract] [Full Text] [Related]
12. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle. Mahan LC, Insel PA. Mol Pharmacol; 1986 Jan 23; 29(1):7-15. PubMed ID: 2868411 [Abstract] [Full Text] [Related]
13. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Molenaar P, Sarsero D, Arch JR, Kelly J, Henson SM, Kaumann AJ. Br J Pharmacol; 1997 Jan 23; 120(2):165-76. PubMed ID: 9117106 [Abstract] [Full Text] [Related]
14. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR. Circulation; 2003 May 20; 107(19):2459-66. PubMed ID: 12743001 [Abstract] [Full Text] [Related]
15. Comparison of binding of 125I-iodopindolol to control and desensitized cells at 37 degrees and on ice. Toews ML, Waldo GL, Harden TK, Perkins JP. J Cyclic Nucleotide Protein Phosphor Res; 1986 May 20; 11(1):47-62. PubMed ID: 3009571 [Abstract] [Full Text] [Related]
16. The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet JM, Leclerc JL, Chatelain P, Christophe J. Mol Pharmacol; 1983 Sep 20; 24(2):169-73. PubMed ID: 6136900 [Abstract] [Full Text] [Related]
17. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Hoyer D, Reynolds EE, Molinoff PB. Mol Pharmacol; 1984 Mar 20; 25(2):209-18. PubMed ID: 6142414 [Abstract] [Full Text] [Related]
18. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. Hedberg A, Gerber JG, Nies AS, Wolfe BB, Molinoff PB. J Pharmacol Exp Ther; 1986 Oct 20; 239(1):117-23. PubMed ID: 3020227 [Abstract] [Full Text] [Related]
19. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor. Lanier SM, Hess HJ, Grodski A, Graham RM, Homcy CJ. Mol Pharmacol; 1986 Mar 20; 29(3):219-27. PubMed ID: 3005829 [Abstract] [Full Text] [Related]
20. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells. Jasper JR, Motulsky HJ, Insel PA. J Pharmacol Exp Ther; 1988 Mar 20; 244(3):820-4. PubMed ID: 2908047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]